Pseudomonas aeruginosa Nos. 1 and 5, each co-existing growth-inhibitor-producing and-nonproducingcells, were used in this study. An equal number of both cells (each 10
8 CFU/mouse) waschallenged intraperitoneally to mice, and these cells in the heart blood and kidneys of mice weredetermined. Furthermore, the effect of piperacillin, ceftazidime and sisomicin on the cell distributionin mice was studied in the model infection due to
P. aeruginosa Nos. 1 and 5. As a control experimentboth cells of
P. aeruginosa No.1 were each challenged intraperitoneally at a dose of 10
8 CFU/mouse tomice of two groups, but there were no marked differences between the two types in cell counts of theheart blood or kidneys 9 hours after challenge.
When a concomitant challenge of both cells (each 10
8 CFU/mouse) was performed
in mice, thenumber of growth-inhibitor-producing cells of the heart blood and kidneys was about 100 times greaterthan that of the non-producing cells. These
in vivo results were well comparable to the previous invitro results and indicated that the inhibitor affected the invasion of the non-producing bacteria in thebody in the model infection due to
P. aeruginosa isolates consisting of the two types of cells. Similarresults were obtained in mice with the model infection due to
P. aeruginosa No.5.
Anti-pseudomonal drugs such as piperacillin (50 mg/mouse) and ceftazidime (50 mg/mouse) andsisomicin (1 mg/mouse) were given intramuscularly to mice infected concomitantly with both cells of
P. aeruginosa No.1. Nine hours after challenge (8 hours after dosing), these cells in the blood andkidneys of mice were determined. The number of growth-inhibitor-producing cells (drug-susceptible) in the heart blood and kidneys of mice decreased markedly, as compared with that of the non-treatedmice. On the other hand, the number of the non-producing cells (multi-drug resistant) in the heartblood and kidneys of infected mice increased markedly, as compared with that of the non-treated mice.
These results also suggested that cells of
P. aeruginosa isolates differed in production of growthinhibitor, invaded into the body through the interaction under given environmental conditionsincluding antibacterial action of the administered drug.
View full abstract